Skip to content

News / Analytics / Reviews

Stock Market Analysis
Corporate News
Financial News

Johnson & Johnson in charts: Innovative Medicine +10% Y/Y in Q4 led by DARZALEX’s 26.6% rise

Posted on January 21, 2026 by wpadmin

Posted in Corporate NewsTagged JNJ

Post navigation

Previous: Elon Musk’s most boring company is making a lot of noise in Nevada

Next: Nvidia CEO discusses AI bubble, infrastructure buildout at Davos

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Search

Recent Posts

SpaceX racing for IPO as Elon Musk eyes space AI data centers: report
Elon Musk warns of a slow pace of Cybercab and Optimus production
Nvidia CEO discusses AI bubble, infrastructure buildout at Davos
Johnson & Johnson in charts: Innovative Medicine +10% Y/Y in Q4 led by DARZALEX’s 26.6% rise
Elon Musk’s most boring company is making a lot of noise in Nevada

Recent Comments

Tom Ford on Affirm: A Genuine Innovation In Finance
Tim Donohue on Tilray Brands Q3 Earnings: Another Disappointing Quarter
PAUL URSUL on Lucid Troubles Keep Building
Warpaint on AT&T: A Classic Value Trap
Tyrion Lannister on Microsoft: AI, A Product Development Boon

Archives

Categories

Corporate News
Financial News
Stock Market Analysis

Powered By WordPress | Newsmagify